Announcement PDF Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 1 / 8 Announcement Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type New announcement Date of this announcement 20/10/2025 The Proposed issue is: Total number of +securities proposed to be issued for an offer of securities under a securities purchase plan ASX +security code +Security description Maximum Number of +securities to be issued New class-code to be confirmed OPTION EXPIRING 31-OCT-2027 EX $0.039 166,666,667 RAD ORDINARY FULLY PAID 166,666,667 +Record date 17/10/2025 Offer closing date 28/11/2025 +Issue date 5/12/2025 Refer to next page for full details of the announcement An offer of securities under a securities purchase plan Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 2 / 8 Part 1 - Entity and announcement details 1.1 Name of +Entity RADIOPHARM THERANOSTICS LIMITED We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules. If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation). 1.2 Registered Number Type ACN Registration Number 647877889 1.3 ASX issuer code RAD 1.4 The announcement is 1.5 Date of this announcement 20/10/2025 1.6 The Proposed issue is: An offer of +securities under a +securities purchase plan New announcement Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 3 / 8 Part 4 - Details of proposed offer under securities purchase plan Part 4A - Conditions 4A.1 Do any external approvals need to be obtained or other conditions satisfied before the offer of +securities under the +securities purchase plan issue can proceed on an unconditional basis? 4A.1a Conditions Approval/Condition +Security holder approval Date for determination 4/12/2025 Is the date estimated or actual? ** Approval received/condition met? Comments The SPP Shares announced 20 October 2025 meet the requirements of listing rule 7.2 exception 5. The SPP Options require shareholder approval. Estimated Yes Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 4 / 8 Part 4B - Offer details +Class or classes of +securities that will participate in the proposed issue and +class or classes of +securities proposed to be issued ASX +security code and description RAD : ORDINARY FULLY PAID Will the proposed issue of this +security include an offer of attaching +securities? Details of +securities proposed to be issued ASX +security code and description RAD : ORDINARY FULLY PAID Maximum total number of those +securities that could be issued if all offers under the +securities purchase plan are accepted 166,666,667 Will the offer be conditional on applications for a minimum number of +securities being received or a minimum amount being raised (i.e. a minimum subscription condition)? Will the offer be conditional on applications for a maximum number of +securities being received or a maximum amount being raised (i.e. a maximum subscription condition)? Describe the maximum subscription condition Maximum of $5,000,000 Will individual security holders be required to accept the offer for a minimum number or value of +securities (i.e. a minimum acceptance condition)? Will individual security holders be limited to accepting the offer for a maximum number or value of +securities (i.e. a maximum acceptance condition)? Is the maximum acceptance unit based or dollar based? Please enter the maximum acceptance value 30,000 Describe all the applicable parcels available for this offer in number of securities or dollar value $2,500 to $10,000 in parcel sizes of $2,500 increments $10,000 to $30,000 in parcel sizes of $5,000 increments Offer price details Unit based Yes No Yes No Yes Unit based Yes No Yes No Yes Unit based Yes No Yes No Yes Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 5 / 8 Has the offer price been determined? In what currency will the offer be made? AUD - Australian Dollar What is the offer price per +security? AUD 0.03000 Oversubscription & Scale back details Will a scale back be applied if the offer is over-subscribed? Describe the scale back arrangements If necessary, the Company will scale back applications under the SPP Offer on a pro rata basis based on the size of the shareholding of each applicant under the SPP Offer as at the Record Date. If a scale back is necessary, the scale back will be applied at the discretion of the Board. Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Attaching +Security The proposed attaching security can only be of an 'Existing class' (additional +securities in a class that is already quoted or recorded by ASX) Attaching +Security - New class (+securities in a class that is not yet quoted or recorded by ASX) Details of attaching +securities proposed to be issued ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them) Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1? Will the entity be seeking quotation of the 'new' class of +securities on ASX? ASX +security code New class-code to be confirmed +Security description OPTION EXPIRING 31-OCT-2027 EX $0.039 +Security type Options Offer ratio (ratio of attaching securities at which the new +securities will be issued) The quantity of attaching +securities to be issued 1 For a given quantity of the new +securities issued 1 What will be done with fractional entitlements? Fractions rounded down to the nearest whole number or fractions disregarded Maximum total number of those +securities that could be issued if all offers under the +securities purchase plan are accepted 166,666,667 Offer price details Has the offer price been determined? Yes No New class Yes Yes Yes Yes No New class Yes Yes Yes Yes No New class Yes Yes Yes Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 6 / 8 Has the offer price been determined? In what currency will the offer be made? AUD - Australian Dollar What is the offer price per +security? AUD 0.00000 Please confirm whether the offer of the attaching +securities is a separate offer to the offer pursuant to the +security purchase plan Please confirm whether the attaching +securities are being offered under a +disclosure document or +PDS Oversubscription & Scale back details Will a scale back be applied if the offer is over-subscribed? Describe the scale back arrangements If necessary, the Company will scale back applications under the SPP Offer on a pro rata basis based on the size of the shareholding of each applicant under the SPP Offer as at the Record Date. If a scale back is necessary, the scale back will be applied at the discretion of the Board. Will all the +securities issued in this class rank equally in all respects from their issue date? Options details +Security currency AUD - Australian Dollar Exercise price AUD 0.0390 Expiry date 31/10/2027 Details of the type of +security that will be issued if the option is exercised RAD : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised One RAD Ordinary Fully Paid Share will be issued for each option exercised Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. Announcement and Prospectus dated 20 October 2025 https://www.asx.com.au/markets/trade-our-cash-market/announcements.rad Part 4C - Timetable 4C.1 Date of announcement of +security purchase plan 20/10/2025 4C.2 +Record date 17/10/2025 Yes Yes Yes No Yes Yes Yes Yes No Yes Yes Yes Yes No Yes Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 7 / 8 4C.3 Date on which offer documents will be made available to investors 24/10/2025 4C.4 Offer open date 24/10/2025 4C.5 Offer closing date 28/11/2025 4C.7 +Issue date and last day for entity to announce results of +security purchase plan offer 5/12/2025 Part 4D - Listing Rule requirements 4D.1 Does the offer under the +securities purchase plan meet all of the requirements of listing rule 7.2 exception 5 or do you have a waiver from those requirements? 4D.1a Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 4D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? Part 4E - Fees and expenses 4E.1 Will there be a lead manager or broker to the proposed offer? 4E.1a Who is the lead manager/broker? Bell Potter Securities limited 4E.1b What fee, commission or other consideration is payable to them for acting as lead manager/broker? SPP Fee: 6% of total proceeds from any share purchase plan under the Offer Option Exercise Fee: 1% on gross proceeds from the exercise of any options issued under the Offer 4E.2 Is the proposed offer to be underwritten? 4E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? 4E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer No No Yes No No No Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 8 / 8 Part 4F - Further Information 4F.01 The purpose(s) for which the entity intends to use the cash raised by the proposed issue The proceeds will primarily be used to fund drug manufacturing, clinical trials and working capital 4F.1 Will the entity be changing its dividend/distribution policy if the proposed offer is successful? 4F.2 Countries in which the entity has +security holders who will not be eligible to accept the proposed offer 4F.3 URL on the entity's website where investors can download information about the proposed offer https://radiopharmtheranostics.com/announcements/#announcements 4F.4 Any other information the entity wishes to provide about the proposed offer Refer announcement dated 20 October 2025 No No